IKZF1: a critical role in the pathogenesis of systemic lupus erythematosus?

REFERENCES

• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929–39.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang S, Chen JJ, et al. Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. Arch Dermatol Res. 2007;298:485–91.
   PubMed Web of Science ®Google Scholar
• Hom G, Graham RR, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358:900–9.
   PubMed Web of Science ®Google Scholar
• Harley JB, Alarck-Riquelme ME, Criswell LA, et al. Genome-wide association scan in women with systemic lupus erythema-tosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008;40:204–10.
   PubMed Web of Science ®Google Scholar
• Kozyrev SV, Abelson AK, Wojcik J, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus ery-thematosus. Nat Genet. 2008;40:211–6.
   PubMed Web of Science ®Google Scholar
• Graham RR, Cotsapas C, Davies L, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythe-matosus. Nat Genet. 2008;40:1059–61.
   PubMed Web of Science ®Google Scholar
• Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009;41: 1234–7.
   PubMed Web of Science ®Google Scholar
• Loeper S, Asa SL, Ezzat S. Ikaros modulates cholesterol uptake: a link between tumor suppression and differentiation. Cancer Res. 2008;68:3715–23.
   Google Scholar
• Rebollo A, Schmitt C. Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies. Immunol Cell Biol. 2003; 81:171–5.
   PubMed Web of Science ®Google Scholar
• Winandy S, Wu P, Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lym-phoma. Cell. 1995;83:289–99.
   Google Scholar
• Yap WH, Yeoh E, Tay A, Brenner S, Venkatesh B. STAT4 is a target of the hematopoietic zinc-finger transcription factor Ikaros in T cells. FEBS Lett. 2005;579: 4470–8.
   Google Scholar
• Movassagh M, Laderach D, Galy A. Proteins of the Ikaros family control dendritic cell maturation required to induce optimal Thl T cell differentiation. Int Immunol. 2004;16:867–75.
   Google Scholar
• Allman D, Dalod M, Asselin-Paturel C, et al. Ikaros is required for plasmacytoid dendritic cell differentiation. Blood. 2006;108: 4025–34.
   Google Scholar
• Dijon M, Bardin F, Murati A, Batoz M, Chabannon C, Tonnelle C. The role of Ikaros in human erythroid differentiation. Blood. 2008;111:1138–46.
   PubMed Web of Science ®Google Scholar
• Harker N, Naito T, Cortes M, Hostert A, Hirschberg S, Tolaini M, Roderick K, Georgopoulos K, Kioussis D. The CD8-alpha gene locus is regulated by the Ikaros family of proteins. Molec Cell. 2002;10: 1403–15.
   Google Scholar
• Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 1994;79:143–56.
   Google Scholar
• Georgopoulos K, Winandy S, Avitahl N. The role of the Ikaros gene in lymphocyte development and homeostasis. Annu Rev Immunol. 1997;15:155–76.
   PubMed Web of Science ®Google Scholar
• He CF, Liu YS, Cheng YL, et al. TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus. 2010;19:1181–6.
   PubMed Web of Science ®Google Scholar
• Hu W, Sun L, Gao J, et al. Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Rheumatol Int. 2011;31:819–22.
   PubMed Web of Science ®Google Scholar
• Cunninghame Graham DS, Morris DL, Bhangale TR, et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 withsystemic lupus erythematosus. PLoS Genet 2011;7 (Epub Oct 27 2011).
   Google Scholar
• Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev. 2004;202: 139–56.
   Google Scholar
• Morinobu A, Gadina M, Strober W, et al. STAT4 serine phos-phorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci. 2002;99: 12281–6.
   PubMed Web of Science ®Google Scholar
• Hom G, Graham RR, Modrek B, Taylor ICE, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358:900–9.
   PubMed Web of Science ®Google Scholar
• Yang W, Ng P, Zhao M, Hirankam N, et al. Population differ-ences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun. 2009;10:219–26.
   PubMed Web of Science ®Google Scholar
• Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 2004;202:8–32.
   Google Scholar
• Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type I inter-feron induction in systemic autoimmunity. Nat Med. 2007;13: 543–51.
   Google Scholar
• Davis AM, Ramos RI, Davis LS, Farrar JD. Cutting edge: a T-bet-independent role for IFN-alb in regulating IL-2-secretion in human CD4 + central memory T cells. J Immunol. 2008;181: 8204–8.
   PubMed Web of Science ®Google Scholar
• Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 2003;19:225–34.
   PubMed Web of Science ®Google Scholar
• Rönnblom LE, Alm GV, Dberg ICE. Autoimmunity after a-interferon therapy for malignant carcinoid tumors. Ann Intern Med. 1991;115:178–83.
   Google Scholar
• Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 1982;25: 401–6.
   PubMed Web of Science ®Google Scholar
• Bengtsson A, Sturfelt G, Truedsson L, et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not antiretroviral antibodies. Lupus. 2000;9: 664–71.
   PubMed Web of Science ®Google Scholar
• Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-induc-ible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci. 2003;100:2610–5.
   PubMed Web of Science ®Google Scholar
• Mathian A, Gallegos M, Pascual V, Banchereau J, Koutouzov S. Interferon-a induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB x NZW)F1 mice but not in BALB/c mice. Eur J Immunol. 2011;41: 863–72.
   Google Scholar
• Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 2008;19: 3–19.
   Google Scholar
• Thomas RM, Chen C, Chunder N, Ma L, Taylor J, Pearce EJ, Wells AD. Ikaros silences T-bet expression and interferon-gamma production during T helper 2 differentiation. J Biol Chem. 2010;285: 2545–53.
   Google Scholar
• Sandling JK, Gamier S, Sigurdsson S, et al. A candidate gene study of the type I interferon pathway implicates IICBICE and IL8 as risk loci for SLE. Eur J Hum Genet. 2011;19:479–84.
   PubMed Web of Science ®Google Scholar
• Fang CM, Roy S, Nielsen E, Paul M, Maul R, Paun A, Koentgen F, Raval FM, Szomolanyi-Tsuda E, Pitha PM. Unique contribu-tion of IRF-5-Ikaros axis to the B-cell IgG2a response. Genes Immun. 2012 Apr 26 [Epub ahead of print].
   Google Scholar
• Klug CA, Morrison SJ, Masek M, Hahm K, Smale ST, Weissman IL. Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochro-matin in immature lymphocytes. Proc Nat Acad Sci 1998;95: 657–662.
   PubMed Web of Science ®Google Scholar
• Ganesh SK, Zakai NA, van Rooij FJ, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet. 2009;41:1191–8.
   PubMed Web of Science ®Google Scholar
• Tefferi A, Vainchenker W. Myeloproliferative neoplasms: molec-ular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol. 2011;29:573–82.
   PubMed Web of Science ®Google Scholar
• Klampfl T, Harutyunyan A, Berg T, et al. Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Blood. 2011;118:167–76.
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446:758–64.
   PubMed Web of Science ®Google Scholar
• Trevino LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1001–5.
   PubMed Web of Science ®Google Scholar
• Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of child-hood acute lymphoblastic leukemia. Nat Genet. 2009;41: 1006–10.
   Google Scholar
• Bematsky S, Boivin JF, Joseph L, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum. 2005;52:1481–90.
   PubMedGoogle Scholar
• Bjomadal L, Lofstrom B, Yin L, Lundberg I, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol. 2002;31:66–71.
   Google Scholar
• Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:761–8.
   PubMed Web of Science ®Google Scholar
• Konstantopoulos K, Terpos E, Prinolakis H, et al. Systemic lupus erythematosus presenting as myelofibrosis. Haematologia (Budap). 1998;29:153–6.
   PubMedGoogle Scholar
• Sliesoraitis S, Khan R, Rothman J. Methotrexate-induced Hodgkin disease in a patient with systemic lupus erythematosus. J Am Osteopath Assoc. 2009;109:325–8.
   Google Scholar
• Nemoto I, Sato-Matsumura KC, Fujita Y, Natsuga K, Ujiie H, Tomita Y, Kato N, Kondo M, Ohnishi K. Leukaemic dissemi-nation of Merkel cell carcinoma in a patient with systemic lupus erythematosus. Clin Exp Dermatol. 2008;33:270–2.
   PubMed Web of Science ®Google Scholar
• Fritsch-Stork RD, Leguit RJ, Derksen RH. Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE. Nat Rev Rheumatol. 2009;5: 283–7.
   Google Scholar